Olivier Nicole < Olivier Rascol < Olivier Toulza

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 92.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000009 (2015)	Olivier Rascol [France] ; Santiago Perez-Lloret ; Joaquim J. Ferreira [Portugal]	New treatments for levodopa-induced motor complications.
000087 (2013)	Fabrizio Stocchi [Italie] ; Olivier Rascol ; Alain Destée [France] ; Nobutaka Hattori ; Robert A. Hauser ; Anthony E. Lang ; Werner Poewe [Autriche] ; Mark Stacy ; Eduardo Tolosa ; Haitao Gao ; Jennifer Nagel ; Martin Merschhemke ; Ana Graf ; Christopher Kenney ; Claudia Trenkwalder	AFQ056 in Parkinson patients with levodopa-induced dyskinesia: 13-week, randomized, dose-finding study.
000103 (2012)	Wassilios G. Meissner [France] ; Alexandra Foubert-Samier ; Sandrine Dupouy ; Angélique Gerdelat-Mas ; Rachel Debs ; Fabienne Marquant ; Valérie Cochen De Cock ; Olivier Rascol ; François Tison ; Anne Pavy-Le Traon	Assessment of quality of life with the multiple system atrophy health-related quality of life scale.
000108 (2012)	Florian Krismer [Autriche] ; Klaus Seppi [Autriche] ; François Tison [France] ; Cristina Sampaio [Portugal] ; Anja Zangerl [Autriche] ; Cecilia Peralta [Autriche, Argentine] ; Farid Yekhlef [France] ; Imad Ghorayeb [France] ; Fabienne Ory-Magne [France] ; Monique Galitzky [France] ; Maria Bozi [Royaume-Uni] ; Tommaso Scaravilli [Royaume-Uni, Italie] ; Carlo Colosimo [Italie] ; Felix Geser [Autriche, Allemagne] ; Olivier Rascol [France] ; Werner Poewe [Autriche] ; Niall P. Quinn [Royaume-Uni] ; Greqor K. Wenning [Autriche]	The Unified Multiple System Atrophy Rating Scale: Intrarater Reliability
000118 (2012)	Andrew Lees (neurologue) [Royaume-Uni] ; Stanley Fahn [États-Unis] ; Karla M. Eggert [Allemagne] ; Joseph Jankovic [États-Unis] ; Anthony Lang [Canada] ; Federico Micheli [Argentine] ; M. Maral Mouradian [États-Unis] ; Wolfgang H. Oertel [Allemagne] ; C. Warren Olanow [États-Unis] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Eduardo Tolosa [Espagne] ; David Squillacote [États-Unis] ; Dinesh Kumar [États-Unis]	Perampanel, an AMPA Antagonist, Found to Have No Benefit in Reducing "Off" Time in Parkinson's Disease
000130 (2012)	Wassilios G. Meissner [France] ; Alexandra Foubert-Samier [France] ; Sandrine Dupouy [France] ; Angélique Gerdelat-Mas [France] ; Rachel Debs [France] ; Fabienne Marquant [France] ; Valérie Cochen De Cock [France] ; Olivier Rascol [France] ; François Tison [France] ; Anne Pavy-Le Traon [France]	Assessment of Quality of Life with the Multiple System Atrophy Health-Related Quality of Life Scale
000141 (2011)	Angelo Antonini [Italie] ; Pablo Martinez-Martin [Espagne] ; Ray K. Chaudhuri [Royaume-Uni] ; Marcelo Merello [Argentine] ; Robert Hauser [États-Unis] ; Regina Katzenschlager [Autriche] ; Per Odin [Allemagne] ; Mark Stacy [États-Unis] ; Fabrizio Stocchi [Italie] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Cristina Sampaio [Portugal] ; Anette Schrag [Royaume-Uni] ; Glenn T. Stebbins [États-Unis] ; Christopher G. Goetz [États-Unis]	Wearing‐off scales in Parkinson's disease: Critique and recommendations
000144 (2011)	Anne Pavy-Le Traon [France] ; Gerard Amarenco [France] ; Susanne Duerr [Autriche] ; Horacio Kaufmann [États-Unis] ; Heinz Lahrmann [Autriche] ; Stephanie R. Shaftman [États-Unis] ; François Tison [France] ; Gregor K. Wenning [Autriche] ; Christopher G. Goetz [États-Unis] ; Werner Poewe [Autriche] ; Cristina Sampaio [Portugal] ; Anette Schrag [Royaume-Uni] ; Glenn T. Stebbins [États-Unis] ; Olivier Rascol [France]	The Movement Disorders task force review of dysautonomia rating scales in Parkinson's disease with regard to symptoms of orthostatic hypotension
000145 (2011)	Klaus Seppi [Autriche, Portugal] ; Daniel Weintraub [États-Unis] ; Miguel Coelho [Portugal] ; Santiago Perez-Lloret [France] ; Susan H. Fox [Canada] ; Regina Katzenschlager [Autriche] ; Eva-Maria Hametner [Autriche] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Christopher G. Goetz [États-Unis] ; Cristina Sampaio [Portugal]	The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the non‐motor symptoms of Parkinson's disease
000146 (2011)	Susan H. Fox [Canada] ; Regina Katzenschlager [Autriche] ; Shen-Yang Lim [Malaisie] ; Bernard Ravina [États-Unis] ; Klaus Seppi [Autriche] ; Miguel Coelho [Portugal] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Christopher G. Goetz [États-Unis] ; Cristina Sampaio [Portugal]	The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease
000157 (2011)	Cristina Sampaio [Portugal] ; Juliana Bronzova [Pays-Bas] ; Robert A. Hauser [États-Unis] ; Anthony E. Lang [Canada] ; Olivier Rascol [France] ; Serge V. Van De Witte [Pays-Bas] ; And Ad Theeuwes [Pays-Bas]	Pardoprunox in early Parkinson's disease: Results from 2 large, randomized double‐blind trials
000165 (2011)	Olivier Rascol [France] ; Andres Lozano [Canada] ; Matthew Stern [États-Unis] ; Werner Poewe [Autriche]	Milestones in Parkinson's disease therapeutics
000171 (2011)	Pablo Martinez-Martin [Espagne] ; Martine Jeukens-Visser [Pays-Bas] ; Kelly E. Lyons [États-Unis] ; C. Rodriguez-Blazquez [Espagne] ; Caroline Selai [Royaume-Uni] ; Andrew Siderowf [États-Unis] ; Mickie Welsh [États-Unis] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Cristina Sampaio [Portugal] ; Glenn T. Stebbins [États-Unis] ; Christopher G. Goetz [États-Unis] ; Anette Schrag [Royaume-Uni]	Health‐related quality‐of‐life scales in Parkinson's disease: Critique and recommendations
000177 (2011)	Emmanuelle Bondon-Guitton [France] ; Santiago Perez-Lloret [France] ; Haleh Bagheri [France] ; Christine Brefel [France] ; Olivier Rascol [France] ; Jean-Louis Montastruc [France]	Drug‐induced parkinsonism: A review of 17 years' experience in a regional pharmacovigilance center in France
000183 (2011)	Anne Pavy-Le Traon [France] ; Gerard Amarenco [France] ; Susanne Duerr [Autriche] ; Horacio Kaufmann [États-Unis] ; Heinz Lahrmann [Autriche] ; Stephanie R. Shaftman [États-Unis] ; François Tison [France] ; Gregor K. Wenning [Autriche] ; Christopher G. Goetz [États-Unis] ; Werner Poewe [Autriche] ; Cristina Sampaio [Portugal] ; Anette Schrag [Royaume-Uni] ; Glenn T. Stebbins [États-Unis] ; Olivier Rascol [France]	The Movement Disorders Task Force Review of Dysautonomia Rating Scales in Parkinson's Disease with Regard to Symptoms of Orthostatic Hypotension
000184 (2011)	Pablo Martinez-Martin [Espagne] ; Martine Jeukens-Visser [Pays-Bas] ; Kelly E. Lyons [États-Unis] ; C. Rodriguez-Blazquez [Espagne] ; Caroline Selai [Royaume-Uni] ; Andrew Siderowf [États-Unis] ; Mickie Welsh [États-Unis] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Cristina Sampaio [Portugal] ; Glenn T. Stebbins [États-Unis] ; Christopher G. Goetz [États-Unis] ; Anette Schrag [Royaume-Uni]	Health-Related Quality-of-Life Scales in Parkinson's Disease: Critique and Recommendations
000185 (2011)	Emmanuelle Bondon-Guitton [France] ; Santiago Perez-Lloret [France] ; Haleh Bagheri [France] ; Christine Brefel [France] ; Olivier Rascol [France] ; Jean-Louis Montastruc [France]	Drug-Induced Parkinsonism: A Review of 17 Years' Experience in a Regional Pharmacovigilance Center in France
000190 (2010)	Carlo Colosimo [Italie] ; Pablo Martínez-Martín [Espagne] ; Giovanni Fabbrini [Italie] ; Robert A. Hauser [États-Unis] ; Marcelo Merello [Argentine] ; Janis Miyasaki [Canada] ; Werner Poewe [Autriche] ; Cristina Sampaio [Portugal] ; Olivier Rascol [France] ; Glenn T. Stebbins [États-Unis] ; Anette Schrag [Royaume-Uni] ; Christopher G. Goetz [États-Unis]	Task force report on scales to assess dyskinesia in Parkinson's disease: Critique and recommendations
000194 (2010)	Joaquim J. Ferreira [Portugal] ; Dulce Neutel [Portugal] ; Tiago Mestre [Portugal] ; Miguel Coelho [Portugal] ; Mário M. Rosa [Portugal] ; Olivier Rascol [France] ; Cristina Sampaio [Portugal]	Skin cancer and Parkinson's disease
000197 (2010)	Birgit Högl [Autriche] ; Isabelle Arnulf [France] ; Cynthia Comella [États-Unis] ; Joaquim Ferreira [Portugal] ; Alex Iranzo [Espagne] ; Barbara Tilley [États-Unis] ; Claudia Trenkwalder [Allemagne] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Cristina Sampaio [Portugal] ; Glenn T. Stebbins [États-Unis] ; Anette Schrag [Royaume-Uni] ; Christopher G. Goetz [États-Unis]	Scales to assess sleep impairment in Parkinson's disease: Critique and recommendations
000198 (2010)	Karla Eggert [Allemagne] ; David Squillacote [États-Unis] ; Paolo Barone [Italie] ; Richard Dodel [Allemagne] ; Regina Katzenschlager [Autriche] ; Murat Emre [Turquie] ; Andrew Lees (neurologue) [Royaume-Uni] ; Olivier Rascol [France] ; Werner Poewe [Autriche] ; Eduardo Tolosa [Espagne] ; Claudia Trenkwalder [Allemagne] ; Marco Onofrj [Italie] ; Fabrizio Stocchi [Italie] ; Giuseppe Nappi [Italie] ; Vladimir Kostic [Serbie] ; Jagoda Potic [Serbie] ; Evzen Ruzicka [République tchèque] ; Wolfgang Oertel [Allemagne]	Safety and efficacy of perampanel in advanced Parkinson's disease: A randomized, placebo‐controlled study

---

List of associated KwdEn.i

Nombre de documents	Descripteur
70	Humans
57	Parkinson disease
53	Nervous system diseases
47	Parkinson's disease
39	Female
38	Male
36	Parkinson Disease (drug therapy)
34	Middle Aged
29	Aged
27	Severity of Illness Index
22	Antiparkinson Agents (therapeutic use)
21	Treatment
20	Human
18	Antiparkinson Agents (adverse effects)
18	Double-Blind Method
17	Adult
16	Parkinson Disease (physiopathology)
16	Treatment Outcome
14	Dose-Response Relationship, Drug
13	Levodopa
13	Questionnaires
12	Antiparkinson Agents (administration & dosage)
11	Dopamine agonist
11	Levodopa (adverse effects)
11	Levodopa (therapeutic use)
11	Parkinson Disease (complications)
11	Parkinson Disease (diagnosis)
11	Recommendation
11	rating scales
10	Reproducibility of Results
9	Antiparkinson agent
9	Chemotherapy
9	levodopa
8	Double blind study
8	Drug Therapy, Combination
8	Multiple system atrophy
8	Psychometrics
8	clinimetrics
7	Drug Administration Schedule
7	Dyskinesia
7	Follow-Up Studies
7	Parkinson Disease (psychology)
7	Placebo
7	Ropinirole
6	Agonist
6	Disability Evaluation
6	Parkinson Disease (epidemiology)
6	Quality of Life
6	Safety
6	Time Factors
5	Aged, 80 and over
5	Bromocriptine
5	Dopamine Agonists (adverse effects)
5	Dyskinesia, Drug-Induced (etiology)
5	Force
5	Indoles (therapeutic use)
5	Levodopa (administration & dosage)
5	Parkinson Disease (therapy)
5	Pramipexole
5	Reliability
5	dopamine agonists
5	dyskinesia
4	Amine oxidase (flavin-containing)
4	Bromocriptine (therapeutic use)
4	Clinical trial
4	Comparative study
4	Confidence Intervals
4	Cross-Over Studies
4	Deep brain stimulation
4	Depression
4	Evaluation scale
4	France
4	France (epidemiology)
4	French
4	Odds Ratio
4	Pilot Projects
4	Piribedil
4	Prospective Studies
4	Risk Factors
4	Validity
4	deep brain stimulation
4	depression
4	dopamine agonist
4	multiple system atrophy
4	psychometrics
4	reliability
4	validity
3	Age Factors
3	Age of Onset
3	Amantadine (therapeutic use)
3	Benzothiazoles
3	Benzothiazoles (administration & dosage)
3	Deep Brain Stimulation (methods)
3	Disease Progression
3	Diseases of the autonomic nervous system
3	Dopamine Agonists (therapeutic use)
3	Dopamine receptor
3	Early
3	Evaluation Studies as Topic
3	Evidence-based medicine

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/France/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i -k "Olivier Rascol" 

HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i  \
                -Sk "Olivier Rascol" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    France
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Olivier Rascol
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024